Manchester based financial wellness company, Financielle has raised pre-seed funding led by Haatch Ventures, to fund its mission to help millions of women become financially sound. Financielle was set up by sisters Laura Pomfret and Holly Holland who started the business back in 2018 on Instagram and have since bootstrapped

Foresight Group (Foresight), a listed infrastructure and regional private equity investment manager, has sold, subject to regulatory approval, portfolio company Codeplay Software Limited (Codeplay) to a US corporate buyer on 31 May 2022. Codeplay is a UK provider of solutions for the semiconductor industry, accelerating the performance of computer chips

Trovata, a fintech focused on corporate banking APIs, announced it has opened offices in London and Amsterdam to support its European expansion plans, having closed a $27 million Series B funding round, led by Fin Capital. Existing investors, JPMorgan Chase Strategic Investments, Wells Fargo Strategic Capital, Capital One Ventures, and

Global private equity investor the Riverside Company has added DroneCurriculum(dot)net to its iCEV platform. DroneCurriculum(dot)net develops drone-related content, curriculum and instructional materials for the K-12 market. This is an add-on to Riverside’s iCEV investment, a developer of SaaS-based digital curriculum, instructional materials and industry certifications for the Career and Technical

JPIN, the largest bilateral bank across UK and India has raised $20 million in Seed to Series A commitments to support high-growth early-stage businesses at a a fintech global investor meet. JPIN is aiming to raise another $35 million through relationships made during the pitch day in collaboration with leading

Ironbridge Equity Partners (Ironbridge) together with certain other minority investors, has completed the sale of Thermogenics to an entity controlled by Audax Private Equity (Audax). The financial terms of the transaction have not been disclosed. Over the course of its investment, Ironbridge supported management’s efforts to expand the Canadian presence

Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, has completed a $60 million Series D financing from a syndicate of global investors with expertise in investing in the biopharmaceutical and life sciences sectors.